These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8222550)
1. [Nizatidine: a meta-analytical study]. di Ciommo V; Ferrario F Clin Ter; 1993 Sep; 143(3):201-7. PubMed ID: 8222550 [TBL] [Abstract][Full Text] [Related]
2. [Modern trends in the treatment of ulcer disease (clinical study of nizatidine "Galitidine")]. Dzambas D; Zivanović M; Majoros J; Petrović Z; Barjaktarović M; Hadnadev L; Tomić Z; Mrda Z; Damjanov D Med Pregl; 1992; 45(9-10):353-8. PubMed ID: 1344473 [TBL] [Abstract][Full Text] [Related]
3. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study. Bovero E; Poletti M; Boero A; Mura BC; Camarri E; Corradini P; Corsini G; Federici G; Curzio M; Gianquinto G Hepatogastroenterology; 1987 Dec; 34(6):269-71. PubMed ID: 2892768 [TBL] [Abstract][Full Text] [Related]
4. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study. Di Mario F; Battaglia G; Saggioro A; Chiozzini P; D'Angelo A; Marin R; Morelli A; Vezzadini P; Buscarini L; Cavassini G Ital J Gastroenterol; 1991 Jun; 23(5):253-6. PubMed ID: 1742515 [TBL] [Abstract][Full Text] [Related]
6. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers. Levendoglu H; Mehta B; Wait C; Reddy G; Hatcher C Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607 [TBL] [Abstract][Full Text] [Related]
7. Peptic ulcer in the elderly--a double-blind, short-term study comparing nizatidine 300 mg with ranitidine 300 mg. GISU (Interdisciplinary Ulcer Study Group). Battaglia G; Di Mario F; Vigneri S; Dal Santo P; Pilotto A; Mazzacca G Aliment Pharmacol Ther; 1993 Dec; 7(6):643-8. PubMed ID: 8161671 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Poynard T; Lemaire M; Agostini H Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162 [TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg. Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117 [TBL] [Abstract][Full Text] [Related]
10. The effect of nizatidine on duodenal ulcer healing and on mucosal inflammatory mediators. Eliakim R; Stalnikowicz R; Ackerman Z; Karmeli F; Rachmilewitz D Isr J Med Sci; 1994 Oct; 30(10):751-6. PubMed ID: 7960687 [TBL] [Abstract][Full Text] [Related]
11. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820 [TBL] [Abstract][Full Text] [Related]
12. Nizatidine versus ranitidine in the prevention of duodenal ulcer relapse. Six-month interim results of a European multicentre study. Hentschel E; Schütze K; Reichel W; Kerstan E; Kratochvil P; Brandstätter G; Judmaier G; Keohane PP Scand J Gastroenterol Suppl; 1987; 136():84-8. PubMed ID: 2892260 [TBL] [Abstract][Full Text] [Related]
13. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons]. Holtmann G; Layer P; Goebell H Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357 [TBL] [Abstract][Full Text] [Related]
14. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial. Russo A; Dattilo M Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183 [TBL] [Abstract][Full Text] [Related]
15. Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient. Nakano T; Kuroiwa T; Tsumita Y; Kaneko Y; Hiromura K; Ueki K; Nojima Y Clin Exp Nephrol; 2004 Jun; 8(2):160-2. PubMed ID: 15235935 [TBL] [Abstract][Full Text] [Related]
16. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Koch M; Dezi A; Ferrario F; Capurso I Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239 [TBL] [Abstract][Full Text] [Related]
17. [Effectiveness and tolerance of selected Polish antacids in the therapy of duodenal ulcer disease. A placebo- and ranitidine-controlled study]. Mach T Pol Tyg Lek; 1995; 50(1-35):797-800. PubMed ID: 11785199 [TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642 [TBL] [Abstract][Full Text] [Related]
19. Use of histamine2-antagonists for the treatment of verruca vulgaris. Fit KE; Williams PC Ann Pharmacother; 2007 Jul; 41(7):1222-6. PubMed ID: 17535844 [TBL] [Abstract][Full Text] [Related]
20. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori]. Carrère MO; Auquier P; Poynard T; Sambuc R Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]